$PHIO 3 SEC Filings

Filed On	Filing
30 Jul 2026	Form 3: Plott Ronald Todd, Director No securities owned
18 Jun 2025	Form 3: Carson Lisa Cabott, VP, Finance and Administration No securities owned
04 Mar 2025	Form 3: Deming David H, Director No securities owned
09 Aug 2024	Form 3: Infarinato Robert M., VP, Chief Financial Officer No securities owned
29 Apr 2022	Form 3: Bradford Patricia A, Director No securities owned
04 Nov 2019	Form 3: Ferrara Robert L, Director No securities owned
24 Apr 2019	Form 3: Barrett John A, Chief Development Officer No securities owned
07 Jun 2017	Form 3: Freeman Jonathan E, Director No securities owned
26 Apr 2017	Form 3: Dispersyn Gerrit, Chief Development Officer No securities owned
17 Jan 2017	Form 3: Eliseev Alexey, Chief Business Officer Holds 817,813 shares of Common stock, $0.0001 par value
22 Apr 2013	Form 3: Lockshin Curtis, Director No securities owned
22 Apr 2013	Form 3: Dorman H. Paul, Director No securities owned
19 Mar 2013	Form 3: Advanced Rna Technologies, Llc, 10% owner Holds 41,259,266 shares of Common Stock, $0.0001 par value
13 Mar 2013	Form 3: Opko Health, Inc., 10% owner Holds 67,241,380 shares of Common Stock
01 Mar 2013	Form 3: Galena Biopharma, Inc., 10% owner Holds 33,476,595 shares of Common stock, $0.0001 par value
01 Mar 2013	Form 3: Cauwenbergh Geert, Director
01 Mar 2013	Form 3: Pavco Pamela, Chief Development Officer Holds 90,153 shares of Common stock, par value $0.0001
01 Mar 2013	Form 3: Kontulis Caitlin, Secretary and Controller Holds 2,231 shares of Common stock, par value $0.0001
01 Mar 2013	Form 3: Brownlie Keith L, Director
01 Mar 2013	Form 3: Bitterman Robert J, Director

Comments